Literature DB >> 20490727

Prevention of venous thromboembolism according to the guidelines of a domestic manual.

Toshihiro Kaneko, Hideo Wada, Tsutomu Nobori, Norikazu Yamada, Mashio Nakamura, Masaaki Ito.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20490727     DOI： 10.1007/s12185-010-0598-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  7 in total

Review 1.  Prevention of venous thromboembolism.

Authors:  W H Geerts; J A Heit; G P Clagett; G F Pineo; C W Colwell; F A Anderson; H B Wheeler
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

2.  Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.

Authors:  A N Nicolaides; H K Breddin; J Fareed; S Goldhaber; S Haas; R Hull; E Kalodiki; K Myers; M Samama; A Sasahara
Journal:  Int Angiol       Date:  2001-03       Impact factor: 2.789

3.  Cut-off values of D-dimer and soluble fibrin for prediction of deep vein thrombosis after orthopaedic surgery.

Authors:  Akihiro Sudo; Hideo Wada; Tsutomu Nobori; Norikazu Yamada; Masaaki Ito; Rui Niimi; Masahiro Hasegawa; Koji Suzuki; Atsumasa Uchida
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

4.  A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement.

Authors:  G Agnelli; S Haas; J S Ginsberg; K A Krueger; A Dmitrienko; J T Brandt
Journal:  J Thromb Haemost       Date:  2007-04       Impact factor: 5.824

5.  Venous thromboembolism in elective operations: balancing the choices.

Authors:  Motaz Qadan; Margaret Tyson; Michael H McCafferty; Sam F Hohmann; Hiram C Polk
Journal:  Surgery       Date:  2008-10       Impact factor: 3.982

6.  Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery.

Authors:  D J Quinlan; J W Eikelboom; O E Dahl; B I Eriksson; P S Sidhu; J Hirsh
Journal:  J Thromb Haemost       Date:  2007-04-07       Impact factor: 5.824

7.  Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Authors:  C W Colwell; S D Berkowitz; B L Davidson; P A Lotke; J S Ginsberg; J R Lieberman; J Neubauer; J L McElhattan; G R Peters; C W Francis
Journal:  J Thromb Haemost       Date:  2003-10       Impact factor: 5.824
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.